Viking Therapeutics Stock Forecast 2021


This is 5.46% less than the trading day before tuesday, 30th nov 2021. Viking therapeutics last posted its earnings data on november 3rd, 2021.


3 Strong Buy Stocks Under 10 That Are Poised To Take Off Nasdaq

The average price target represents a 170.16% change from the last price of $6.20.

Viking therapeutics stock forecast 2021. Vktx) is owned by 48.27% institutional shareholders, 11.87% viking therapeutics insiders, and 39.85% retail investors. This suggests a possible upside of 174.6% from the stock's current price. Get the hottest stocks to trade every day before the market.

Vktx) is scheduled to announce q3 earnings results on wednesday, november 3rd, after market close. View analysts' price targets for viking therapeutics or view. Their forecasts range from $13.00 to $21.00.

With the market capitalization of viking therapeutics inc. Viking therapeutics q3 2021 earnings preview. 26, 2020 when the stock price was at 8.11$.

For viking therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average viking therapeutics stock forecast of $5.01, a high forecast of $5.41, and a low forecast of $4.71. In the medium term (3months), vktx's stock price should underperform the market by. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report.

116 rows viking therapeutics inc stock forecast, vktx stock predictons by days: Viking therapeutics recently reported their q1 earnings that revealed the company still has a strong cash position to help fund their impressive pipeline. Everything about viking therapeutics inc's forecasts and estimates, including earnings per share, sales, earnings trends for 2021, 2022, etc.

The company report on april 29, 2021 that viking therapeutics reports first quarter 2021 financial results and provides corporate update. For the purposes of this article, insiders are. Based on 5 wall street analysts offering 12 month price targets for viking therapeutics in the last 3 months.

Pharmaceuticals inc ligand is the largest individual viking therapeutics shareholder, owning 5.82m shares representing 7.44% of the company. During the day the stock fluctuated 8.37% from a day low at $5.02 to a day high of $5.44. The average price target is $16.75 with a high forecast of $20.00 and a low forecast of $14.00.

273 rows viking therapeutics inc stock price forecast, vktx predictons for2022 Press release reported on 03/04/21 that viking therapeutics to participate at upcoming investor conferences. The biotechnology company reported ($0.17) eps for the quarter, topping the consensus estimate of ($0.21) by $0.04.

Viking therapeutics inc stock forecast. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. Vktx stock forecast our latest prediction for viking therapeutics inc's stock price was made on the aug.

On average, they expect viking therapeutics' stock price to reach $15.57 in the next year. Viking therapeutics inc has risen higher in 2 of those 6 years over the subsequent 52 week period, corresponding to a historical accuracy of 33.33 % Viking therapeutics has generated ($0.71) earnings per share over the last year (($0.71) diluted earnings per share).

Viking therapeutics may not be the best stock to buy.so take a peek at this free list of interesting companies with high roe and low debt. Close price at the end of the last trading day (wednesday, 1st dec 2021) of the vktx stock was $5.02. Over the next 52 weeks, viking therapeutics inc has on average historically risen by 54 % based on the past 6 years of stock performance.


Buy The Dip In Viking Therapeutics Stock Says Analyst Nasdaq


Viking Therapeutics Inc Vktx Now Trades Above Golden Cross Time To Buy Nasdaq


What Type Of Shareholders Own The Most Number Of Viking Therapeutics Inc Nasdaqvktx Shares


Viking Therapeutics Stock Remaining Bullish And Sticking To My Plan Nasdaqvktx Seeking Alpha


2 Great Stocks Under 10


Viking Therapeutics Stock Remaining Bullish And Sticking To My Plan Nasdaqvktx Seeking Alpha


27uen07il82lbm


How Much Upside Is Left In Viking Therapeutics Inc Vktx Wall Street Analysts Think 204 Nasdaq


3 Robinhood Penny Stocks With 100 Buy Ratings


3 Strong Buy Biotech Stocks Trading Under 10


89bio And Viking Therapeutics Become Btigs Top Picks In Nash Space Nasdaq Vktx Seeking Alpha


Viking Therapeutics Stock Remaining Bullish And Sticking To My Plan Nasdaqvktx Seeking Alpha


What Type Of Shareholders Own The Most Number Of Viking Therapeutics Inc Nasdaqvktx Shares


Viking Therapeutics Stock Remaining Bullish And Sticking To My Plan Nasdaqvktx Seeking Alpha


Intercept Icpt Beats On Q3 Earnings Sales Ups View Nasdaq


Viking Therapeutics Vktx Stock Price News Info The Motley Fool


Viking Therapeutics Stock Forecast Down To 4228 Usd - Vktx Stock Price Prediction Long-term Short-term Share Revenue Prognosis With Smart Technical Analysis


45 Biggest Movers From Yesterday Markets Insider


Buy Sell Or Hold Viking Therapeutics Inc Vktx-q Stock Predictions At Stockchase


Advertisement